147 related articles for article (PubMed ID: 23406856)
1. [Protective effect of insulin-like growth factor-1 on vascular endothelial function in hypercholesterolemia and the underlying mechanism].
Ji S; Ma Q; Luo X; Peng J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jan; 38(1):36-42. PubMed ID: 23406856
[TBL] [Abstract][Full Text] [Related]
2. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway.
Tan B; Jiang DJ; Huang H; Jia SJ; Jiang JL; Hu CP; Li YJ
Vascul Pharmacol; 2007 May; 46(5):338-45. PubMed ID: 17293168
[TBL] [Abstract][Full Text] [Related]
3. [Protective effect of losartan on injury induced by ox-LDL in endothelial cells and the relationship with asymmetric dimethylarginine].
Xie QY; Sun ZL; Chen MF; Yang TL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):66-9. PubMed ID: 16562679
[TBL] [Abstract][Full Text] [Related]
4. Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor.
Jiang JL; Jiang DJ; Tang YH; Li NS; Deng HW; Li YJ
Acta Pharmacol Sin; 2004 Jul; 25(7):893-901. PubMed ID: 15210062
[TBL] [Abstract][Full Text] [Related]
5. Fenofibrate decreases asymmetric dimethylarginine level in cultured endothelial cells by inhibiting NF-kappaB activity.
Yang TL; Chen MF; Luo BL; Xie QY; Jiang JL; Li YJ
Naunyn Schmiedebergs Arch Pharmacol; 2005 May; 371(5):401-7. PubMed ID: 15915325
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level.
Tang WJ; Hu CP; Chen MF; Deng PY; Li YJ
Can J Physiol Pharmacol; 2006 Feb; 84(2):163-71. PubMed ID: 16900942
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of Nonmuscle Myosin Light Chain Promotes Endothelial Injury in Hyperlipidemic Rats Through a Mechanism Involving Downregulation of Dimethylarginine Dimethylaminohydrolase 2.
Wu Y; Zhang JJ; Li TB; Liu WQ; Li LS; Luo XJ; Jiang JL; Ma QL; Yang ZC; Peng J
J Cardiovasc Pharmacol Ther; 2016 Nov; 21(6):536-548. PubMed ID: 26911182
[TBL] [Abstract][Full Text] [Related]
8. Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells.
Monsalve E; Oviedo PJ; García-Pérez MA; Tarín JJ; Cano A; Hermenegildo C
Cardiovasc Res; 2007 Jan; 73(1):66-72. PubMed ID: 17097077
[TBL] [Abstract][Full Text] [Related]
9. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase.
Ito A; Tsao PS; Adimoolam S; Kimoto M; Ogawa T; Cooke JP
Circulation; 1999 Jun; 99(24):3092-5. PubMed ID: 10377069
[TBL] [Abstract][Full Text] [Related]
10. Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level.
Jiang JL; Li Ns NS; Li YJ; Deng HW
Br J Pharmacol; 2002 Mar; 135(5):1175-82. PubMed ID: 11877324
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of HDL on endothelial NO production: the role of DDAH/ADMA pathway.
Peng ZY; Zhao SP; He BM; Peng DQ; Hu M
Mol Cell Biochem; 2011 May; 351(1-2):243-9. PubMed ID: 21264497
[TBL] [Abstract][Full Text] [Related]
12. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity.
Jiang JL; Zhang XH; Li NS; Rang WQ; Feng-Ye ; Hu CP; Li YJ; Deng HW
Cardiovasc Drugs Ther; 2006 Aug; 20(4):281-94. PubMed ID: 16897158
[TBL] [Abstract][Full Text] [Related]
13. The effect of simvastatin on asymmetric dimethylarginine and flow-mediated vasodilation after optimizing the LDL level: a randomized, placebo-controlled study.
Vladimirova-Kitova LG; Deneva-Koycheva TI
Vascul Pharmacol; 2012; 56(3-4):122-30. PubMed ID: 22108444
[TBL] [Abstract][Full Text] [Related]
14. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
Selley ML
J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
[TBL] [Abstract][Full Text] [Related]
15. Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunction.
Jiang DJ; Jia SJ; Yan J; Zhou Z; Yuan Q; Li YJ
Biochem Biophys Res Commun; 2006 Oct; 349(2):683-93. PubMed ID: 16959216
[TBL] [Abstract][Full Text] [Related]
16. Osthole alleviates oxidized low-density lipoprotein-induced vascular endothelial injury through suppression of transforming growth factor-β1/Smad pathway.
Wang Y; Che J; Zhao H; Tang J; Shi G
Int Immunopharmacol; 2018 Dec; 65():373-381. PubMed ID: 30380512
[TBL] [Abstract][Full Text] [Related]
17. Relationship of asymmetric dimethylarginine with flow-mediated dilatation in subjects with newly detected severe hypercholesterolemia.
Vladimirova-Kitova L; Deneva T; Angelova E; Nikolov F; Marinov B; Mateva N
Clin Physiol Funct Imaging; 2008 Nov; 28(6):417-25. PubMed ID: 18798847
[TBL] [Abstract][Full Text] [Related]
18. Dimethylarginine dimethylaminohydrolase inhibition and asymmetric dimethylarginine accumulation contribute to endothelial dysfunction in rats exposed to glycosylated protein: effects of aminoguanidine.
Yin QF; Fu SH; He P; Xiong Y
Atherosclerosis; 2007 Jan; 190(1):53-61. PubMed ID: 16533509
[TBL] [Abstract][Full Text] [Related]
19. Effects of simvastatin and L-arginine on vasodilation, nitric oxide metabolites and endogenous NOS inhibitors in hypercholesterolemic subjects.
Pereira EC; Bertolami MC; Faludi AA; Salem M; Bersch D; Abdalla DS
Free Radic Res; 2003 May; 37(5):529-36. PubMed ID: 12797474
[TBL] [Abstract][Full Text] [Related]
20. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression.
Gates PE; Boucher ML; Silver AE; Monahan KD; Seals DR
J Appl Physiol (1985); 2007 Jan; 102(1):63-71. PubMed ID: 16946027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
